Abstract:In this paper, we present results with clinical data to enable a 2x2 input–output multivariable patient model for hypnosis and analgesia. Nonlinear multi-drug interaction models are identified from data recorded from 70 patients undergoing surgery during total intravenous anesthesia (TIVA) with several medical monitors for variables such as Bispectral Index, Nociception level (Medasense), skin conductance (Medstorm) and advanced spectral analysis conductance (AnspecPro). Bispectral index measures the depth of hypnosis (lack of consciousness), while nociception related indices from Medasense, Medstorm, and AnspecPro devices measure levels related to analgesia (lack of reaction to noxious stimuli). A comparison is given among three response surface model (RSM) structures – Minto, Greco, and Reduced Greco – for hypnotic and analgesic states during Propofol–Remifentanil interaction. The identified models capture the pharmacodynamic properties of dose–effect concentrations of Propofol/Remifentanil while the pharmacokinetic part of the patient model is calculated from patient's biometric values using Schnider/Minto (SM), and Eleveld/Eleveld (EE) models. In presence of strict clinical protocols delivering data under poor identifiability conditions, we propose two methods of identification: (i) based on steady-state gains, and (ii) using all available data which includes part of the dynamic transient. The model parameters are optimized with Genetic Algorithm based on a goodness of fit performance measure complemented with root mean square error. The results suggest that the EE model combination is advantageous for Bispectral index pharmacokinetic modeling at the cost of numerical complexity, therefore reducing the uncertainty left to be identified in the pharmacodynamic part of the patient model. By contrast, the SM model combination is less computationally demanding and provides some improvement in the RSM accuracy for nociception level indicators. The comparison of three devices for nociception levels evaluation suggests that clinical data captured with the Medasense monitor provides best fitted RSMs with the Reduced Greco RSM structure, despite having fewer parameters.

Real-Time Personalised Pharmacokinetic-Pharmacodynamic Modelling in Propofol Anesthesia through Bayesian Inference

A Novel PBPK/PD Model with Automatic Nervous System in Anesthesia.

Population Pharmacodynamics of Propofol in Neurosurgical Patients

Online identification of pharmacodynamic parameters for closed-loop anesthesia with model predictive control

Application of Ivive and Pbpk Modeling in Prospective Prediction of Clinical Pharmacokinetics: Strategy and Approach During the Drug Discovery Phase with Four Case Studies

Evaluating Propofol Concentration in Blood From Exhaled Gas Using a Breathing-Related Partition Coefficient

Pharmacokinetic/Pharmacodynamic Anesthesia Model Incorporating psi-Caputo Fractional Derivatives

Data-driven identification and comparison of full multivariable models for propofol–remifentanil induced general anesthesia

Automated Multi-Drugs Administration During Total Intravenous Anesthesia Using Multi-Model Predictive Control

A Pharmacokinetics-Neural Mass Model (PK-NMM) for the Simulation of EEG Activity during Propofol Anesthesia

Constructing a control-ready model of EEG signal during general anesthesia in humans

Optimization of Propofol Dose Estimated During Anesthesia Through Artificial Intelligence by Genetic Algorithm: Design and Clinical Assessment

Towards Real-World Applications of Personalized Anesthesia Using Policy Constraint Q Learning for Propofol Infusion Control

A Model-Based Architecture for Automatic Anesthesia Infusion

A Deep Learning Framework for Anesthesia Depth Prediction from Drug Infusion History

Comparison of predicted and real propofol and remifentanil concentrations in plasma and brain tissue during target-controlled infusion: a prospective observational study

Deep learning prediction of patient response time course from early data via neural-pharmacokinetic/pharmacodynamic modeling

Development of extended pharmacokinetic models for propofol based on measured blood and brain concentrations

Bayesian estimation of pharmacokinetic parameters: an important component to include in the teaching of clinical pharmacokinetics and therapeutic drug monitoring

Increasing Robustness of the Anesthesia Process from Difference Patient's Delay Using a State-Space Model Predictive Controller

Implementation of a Bayesian based advisory tool for target-controlled infusion of propofol using qCON as control variable